Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Manchester to open embryonic stem-cell research centre

23.02.2006


Manchester is set to become a major contributor to stem-cell research with the opening of one of the most hi-tech facilities in the UK.



The North West Embryonic Stem Cell Centre, based at St Mary’s Hospital and The University of Manchester, will develop new treatments for diseases such as cancer and diabetes.

The £2 million centre will produce embryonic stem cells of high enough quality for human transplantation – one of only a handful of laboratories in the UK able to do this.


Dr Daniel Brison, a consultant embryologist at St Mary’s and co-director of the stem-cell centre, said the new facility would place Manchester at the cutting edge of developments in embryonic stem-cell research.

“This is a major research grant into the NHS to support the Government’s interest in developing human stem cells for the benefit of patients.

“The centre’s laboratories will be some of the best equipped in the country producing stem-cell lines to Good Manufacturing Practice standards so they can be used for transplantation at a future date.”

The North West Embryonic Stem Cell Centre will ask patients on IVF programmes to donate eggs and embryos that would ordinarily be discarded and develop them in the lab under licence from the Human Fertilisation and Embryology Authority.

Infertile couples will be among those to benefit from the new research centre as knowledge gained about embryonic development will assist the hospital’s IVF programme.

The centre, which is due to open in June 2006, is a joint project between The University of Manchester, the Central Manchester and Manchester Children’s University Hospital NHS Trust, the Paterson Institute for Cancer Research and The University of Liverpool.

Co-director Dr Sue Kimber, from The University of Manchester’s Faculty of Life Sciences, said: “We aim to build on the strong relationship between the Trust and the University to enable us to deliver state-of-the-art medicines for treatment of a wide range of diseases.”

Scientists believe that stem cells – master cells that have the potential to turn into any kind of human tissue – could be used to replace diseased cells in patients suffering from currently incurable diseases like Parkinson’s, Alzheimer’s, diabetes and cancer.

Professor Peter Stern, in The University of Manchester’s Paterson Institute for Cancer Research based at Christie Hospital, will be focussing on the use of embryonic stem cells in the fight against cancer.

He said: “Cancer cells have properties that are similar to those seen in embryonic cells during development except, with cancer, the cells are maliciously activated.

“We will be investigating such shared properties between embryonic stem cells and cancer cells to identify targets where it is possible to develop cancer vaccines.”

A further £1.46 million grant has been awarded to the University to establish a UK Centre for Tissue Regeneration, which will be based adjacent to the stem-cell labs in the new Core Technology Facility on Grafton Street.

Professor Cay Kielty, director of the new tissue-regeneration centre, said: “The award will support the establishment of a tissue-regeneration ‘clean laboratory’ to Good Manufacturing Practice standards.

“The lab will regenerate skin, nerves, cartilage and blood vessels using living cells, including stem cells, under quality-control, sterile conditions for future use in human tissue repair.”

Aeron Haworth | alfa
Further information:
http://www.manchester.ac.uk

More articles from Science Education:

nachricht Starting school boosts development
11.05.2017 | Max-Planck-Institut für Bildungsforschung

nachricht New Master’s programme: University of Kaiserslautern educates experts in quantum technology
15.03.2017 | Technische Universität Kaiserslautern

All articles from Science Education >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>